 |
Amylin Pharma AMLN (news,
chart,
quote) - AMLN volatility Elevated at 58
AMLN closed at $32.38. AMLN is engaged in treatments for diabetes and obesity. Smith Barney say's "Fundamentals remain challenging as Byetta struggles while LAR faces tremendous competition. Only early LAR filing can drive appreciation. Otherwise, we see stock testing low/mid $20 by year end." AMLN June option implied volatility of 58 is above its 6-month average of 52 according to Track Data, suggesting larger price risk.
|
|
|
|
